1. Home
  2. FULC vs SES Comparison

FULC vs SES Comparison

Compare FULC & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.72

Market Cap

281.1M

Sector

Health Care

ML Signal

N/A

Logo SES AI Corporation

SES

SES AI Corporation

N/A

Current Price

$0.85

Market Cap

256.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
FULC
SES
Founded
2015
2012
Country
United States
United States
Employees
55
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
256.7M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FULC
SES
Price
$3.72
$0.85
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $3.67
N/A
AVG Volume (30 Days)
1.4M
★ 25.1M
Earning Date
11-17-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.03
EPS
N/A
★ N/A
Revenue
N/A
★ $21,000,000.00
Revenue This Year
N/A
$55.89
Revenue Next Year
N/A
$131.57
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 929.41
52 Week Low
$2.83
$0.49
52 Week High
$15.74
$2.62

Technical Indicators

Market Signals
Indicator
FULC
SES
Relative Strength Index (RSI) 47.92 54.53
Support Level $3.62 $0.51
Resistance Level $3.81 $0.94
Average True Range (ATR) 0.07 0.10
MACD 0.00 -0.01
Stochastic Oscillator 39.39 67.54

Price Performance

Historical Comparison
FULC
SES

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.

Share on Social Networks: